Concepedia

Sheila Bheddah

SB

Statistics

Publications

13

Citations

2.3K

H-Index

13

Active since

1999

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

ChemoCentryx (United States)

Cornell University

The University of Texas MD Anderson Cancer Center

AbbVie (United States)

Sheila Bheddah is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

1999–2017

13

Publications

13

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

Laura R. Saunders, Alexander J. Bankovich, Wade Anderson et al. · Science Translational Medicine · 2015 · 578 citations

Medicine, Oncology, Pharmacology +17

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

Charles M. Rudin, M. Catherine Pietanza, Todd M. Bauer et al. · The Lancet Oncology · 2016 · 553 citations · Full text

Medicine, Oncology, Pharmacology +15

Ubiquitin Ligase RNF146 Regulates Tankyrase and Axin to Promote Wnt Signaling

Marinella Callow, Hoanh Tran, Lilian Phu et al. · PLoS ONE · 2011 · 225 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

COP1, the Negative Regulator of p53, Is Overexpressed in Breast and Ovarian Adenocarcinomas

David Dornan, Sheila Bheddah, Kim Newton et al. · Cancer Research · 2004 · 140 citations

Life Sciences, Molecular Biology, Oncology +15

Prevalence of Delta-like protein 3 expression in patients with small cell lung cancer

Kentaro Tanaka, Kumiko Isse, Tomomichi Fujihira et al. · Lung Cancer · 2017 · 120 citations

Medicine, Molecular Biology, Oncology +12

1–5 of 13